The role of IFN regulatory factor-3 in the cytotoxic activity of NS-9, a polyinosinic-polycytidylic acid/cationic liposome complex, against tumor cells

Molecular Cancer Therapeutics

Volumn 4, Issue 5, 2005, Pages 799-805

  Uno, Tomonori ^a   Hirabayashi, Kazuko ^a   Murai, Masatoshi ^a   Yano, Junichi ^a   Ozato, Keiko ^b  

^a NIPPON SHINYAKU CO LTD   (Japan)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON RECEPTOR; CYTOTOXIC AGENT; DNA FRAGMENT; DOUBLE STRANDED RNA; GAMMA INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 3; LIPOSOME; NS 9; PROTEIN KINASE; RIBONUCLEASE L; RIBOSOME RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; EPITHELIUM CELL; FIBROBLAST; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; TUMOR CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CATIONS; DNA-BINDING PROTEINS; ENDORIBONUCLEASES; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON-ALPHA; INTERFERON-BETA; LIPOSOMES; POLY I-C; RNA INTERFERENCE; RNA, RIBOSOMAL; TRANSCRIPTION FACTORS;

EID: 20044374362     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-04-0317     Document Type: Article

References (42)

1. Hirabayashi K, Yano J, Inoue T, et al. Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity. Cancer Res 1999;59:4325-33.
2. Field AK, Tytell AA, Lampson GP, Hilleman MR. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A 1967;58:1004-10.
3. Hovanessian AG. The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J Interferon Res 1989;9:641-7.
4. Patel RC, Sen GC. Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J Biol Chem 1992;267:7671-6.
5. McCormack SJ, Ortega LG, Doohan JP, Samuel CE. Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. Virology 1994; 198:92-9.
6. Farrell PJ, Balkow K, Hunt T, Jackson RJ, Trachsel H. Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis. Cell 1997;11:187-200.
7. Levin D, London IM. Regulation of protein synthesis: activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proc Natl Acad Sci U S A 1978;75:1121-5.
8. Samuel CE. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci U S A 1979;76: 600-4.
9. Baglioni C, Maroney PA, West DK. 2′5′ Oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells. Biochemistry 1979;18:1765-70.
10. Nilsen TW, Maroney PA, Baglioni C. Double-stranded RNA causes synthesis of 2′,5′ oligo(A) and degradation of messenger RNA in interferon-treated cells. J Biol Chem 1981;256:7806-11.
11. Clemens MJ, Williams BR. Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 1978;13:565-72.
12. Baglioni C, Minks MA, Maroney PA. Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A. Nature 1978;273:684-7.
13. Ratner L, Wiegand RC, Farrell PJ, Sen GC, Cabrer B, Lengyel P. Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonuclease INT system into two macromolecular components; role of a small molecule in nuclease activation. Biochem Biophys Res Commun 1978;81:947-54.
14. Brown GE, Lebleu B, Kawakita M, Shaila S, Sen GC, Lengyel P. Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA. Biochem Biophys Res Commun 1976;69:114-22.
15. Lee SB, Esteban M. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 1994;199:491-6.
16. Der SD, Yang YL, Weissmann C, Williams BR. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci U S A 1997;94:3279-83.
17. Takizawa T, Ohashi K, Nakanishi Y. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J Virol 1996;70:8128-32.
18. Kibler KV, Shors T, Perkins KB, et al. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J Virol 1997;71: 1992-2003.
19. Yeung MC, Liu J, Lau AS. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc Natl Acad Sci U S A 1996;93:12451-5.
20. Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J 1998;17: 6888-902.
21. Balachandran S, Roberts PC, Kipperman T, et al. α/β Interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol 2000;74:1513-23.
22. Diaz-Guerra M, Rivas C, Esteban M. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 1997;236: 354-63.
23. Castelli JC, Hassel BA, Wood KA, et al. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 1997;186:967-72.
24. Zhou A, Paranjape JM, Hassel BA, et al. Impact of RNase L overexpression on viral and cellular growth and death. J Interferon Cytokine Res 1998;18:953-61.
25. Rusch L, Zhou A, Silverman RH. Caspase-dependent apoptosis by 2′,5′-oligoadenylate activation of RNase L is enhanced by IFN-β. J Interferon Cytokine Res 2000;20:1091-100.
26. Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 1993;12: 3297-304.
27. Zhou A, Paranjape J, Brown TL, et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J 1997; 16:6355-63.
28. Servant MJ, Grandvaux N, Hiscott J. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem Pharmacol 2002;64:985-92.
29. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001;413:732-8.
30. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003; 301:640-3.
31. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat Immunol 2003;4:161-7.
32. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
33. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002; 110:563-74.
34. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002;296: 550-3.
35. Sakahira H, Enari M, Negate S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998;391: 96-9.
36. Tanaka N, Sato M, Lamphier MS, et al. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 1998;3: 29-37.
37. Heylbroeck C, Balachandran S, Servant MJ, et al. The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J Virol 2000;74: 3781-92.
38. Houge G, Robaye B, Eikhom TS, et al. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol Cell Biol 1995;15: 2051-62.
39. Nadano D, Sato TA. Caspase-3-dependent and -independent degradation of 28 S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement. J Biol Chem 2000;275:13967-73.
40. Banerjee S, An S, Zhou A, Silverman RH, Makino S. RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells. J Virol 2000;74:8793-802.
41. Houge G, Doskeland SO, Boe R, Lanotte M. Selective cleavage of 28S rRNA variable regions V3 and V13 in myeloid leukemia cell apoptosis. FEBS Lett 1993;315:16-20.
42. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004;5:730-7.